What is the ‘real-world’ experience with fixed-ratio combination therapy (insulin + GLP-1 receptor agonist) in routine clinical practice? Take-home messages for clinicians regarding key outcomes
Frias JP
Diabetes Obes Metab. Pub. online 10 Jul 2025.
Leggi


